Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-04 Sale |
2022-03-07 8:59 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
3,259 | $16.9 | $55,088 | 1,186,016 (Indirect Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:53 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
1,011 | $16.85 | $17,032 | 90,139 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:49 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
1,023 | $16.85 | $17,234 | 79,311 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:49 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
303 | $16.85 | $5,104 | 70,556 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:48 pm |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
1,023 | $16.85 | $17,234 | 66,413 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-07 8:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
856 | $16.85 | $14,420 | 294,726 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:18 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,153 | $17.75 | $38,222 | 810,640 (Indirect Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:18 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
775 | $17.75 | $13,758 | 246,982 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
420 | $17.75 | $7,456 | 22,259 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
936 | $17.75 | $16,617 | 18,836 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:15 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
935 | $17.75 | $16,599 | 31,734 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 5:55 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $17 | $17,000 | 932,428 (Indirect Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 4:17 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.59 | $21,592 | 933,428 (Indirect Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 5:19 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $21.21 | $53,030 | 221,993 (Indirect Direct) |
View |
| 2021-12-27 Sale |
2021-12-28 5:00 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
12,560 | $20.07 | $252,139 | 22,679 (Direct) |
View |
| 2021-12-23 Sale |
2021-12-23 9:46 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $20.16 | $50,396 | 224,493 (Indirect Direct) |
View |
| 2021-12-08 Sale |
2021-12-10 6:41 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $17 | $17,000 | 934,428 (Indirect Direct) |
View |
| 2021-11-05 Sale |
2021-11-09 5:19 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.5 | $21,502 | 935,428 (Indirect Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 5:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $21.81 | $54,524 | 226,993 (Indirect Direct) |
View |
| 2021-10-05 Sale |
2021-10-07 4:05 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $24.92 | $62,294 | 936,428 (Indirect Direct) |
View |
| 2021-10-01 Sale |
2021-10-05 2:11 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $23.87 | $59,680 | 229,493 (Indirect Direct) |
View |
| 2021-10-01 Sale |
2021-10-05 2:10 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,500 | $25.01 | $37,510 | 938,928 (Indirect Direct) |
View |
| 2021-09-07 Sale |
2021-09-09 5:42 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.14 | $21,137 | 940,428 (Indirect Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 5:07 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,000 | $20.8 | $103,986 | 241,216 (Indirect Direct) |
View |
| 2021-08-05 Sale |
2021-08-09 6:51 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $20.81 | $20,810 | 941,428 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-07 Exercise |
2022-03-07 8:59 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
700 | $0 | 1,186,016 (Direct) |
View |
| 2022-03-07 Exercise |
2022-03-07 8:59 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
700 | $1.6806 | 1,186,016 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:59 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
259,000 | $0 | 1,186,016 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:53 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
64,900 | $0 | 90,139 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:52 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
48,600 | $0 | 48,600 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:49 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
48,600 | $0 | 79,311 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:49 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
48,600 | $0 | 70,556 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:48 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
48,600 | $0 | 66,413 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:47 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
48,600 | $0 | 294,726 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 8:46 pm |
N/A 2032-03-03 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer |
48,600 | $0 | 48,600 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-11 5:55 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 932,428 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-11 5:55 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 932,428 (Direct) |
View |
| 2022-01-05 Exercise |
2022-01-07 4:17 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 933,428 (Direct) |
View |
| 2022-01-05 Exercise |
2022-01-07 4:17 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 933,428 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:43 pm |
N/A 2032-01-03 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru SVP and General Counsel |
185,000 | $0 | 185,000 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:19 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0 | 221,993 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:19 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0.5802 | 221,993 (Direct) |
View |
| 2021-12-30 Option Award |
2022-01-04 9:05 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
16,750 | $0 | 26,250 (Direct) |
View |
| 2021-12-30 Option Award |
2022-01-04 9:05 pm |
N/A 2031-08-23 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
55,704 | $0 | 55,704 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-23 9:46 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0 | 224,493 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-23 9:46 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0.5802 | 224,493 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 6:41 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 934,428 (Direct) |
View |
| 2021-12-08 Exercise |
2021-12-10 6:41 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 934,428 (Direct) |
View |
| 2021-11-05 Exercise |
2021-11-09 5:19 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 935,428 (Direct) |
View |
| 2021-11-05 Exercise |
2021-11-09 5:19 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 935,428 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 5:16 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0 | 226,993 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 5:16 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0.5802 | 226,993 (Direct) |
View |
Ownership(A) |
2021-10-07 4:09 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Leonard Keith R Director |
0 | $0 | 1,750 (Indirect) |
View |
| 2021-10-05 Exercise |
2021-10-07 4:05 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $0 | 936,428 (Direct) |
View |
| 2021-10-05 Exercise |
2021-10-07 4:05 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $1.6806 | 936,428 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 2:11 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0 | 229,493 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 2:11 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
2,500 | $0.5802 | 229,493 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 2:10 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,500 | $0 | 938,928 (Direct) |
View |
| 2021-10-01 Exercise |
2021-10-05 2:10 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,500 | $1.6806 | 938,928 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 5:42 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 940,428 (Direct) |
View |
| 2021-09-07 Exercise |
2021-09-09 5:42 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 940,428 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 7:53 pm |
N/A 2031-09-02 |
Arcutis Biotherapeutics Inc. | ARQT | Leonard Keith R Director |
32,907 | $0 | 32,907 (Direct) |
View |
Ownership |
2021-09-07 7:52 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Leonard Keith R Director |
0 | $0 | 2,500 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 5:07 pm |
N/A 2028-06-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
5,000 | $0 | 241,216 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 5:07 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
4,444 | $1.6806 | 241,216 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 5:07 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
556 | $0.5802 | 241,216 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-09 6:51 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $0 | 941,428 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-09 6:51 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $1.6806 | 941,428 (Direct) |
View |